Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. APGE
6. USO
7. GOOGL
8. HOOD
9. DFTX
10. NAVN

Go back to Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
(NASDAQ: PLRX) Delayed: 1.16 --0 (-0%)
Previous Close $1.16    52 Week High $ 
Open $1.17    52 Week Low $ 
Day High $1.18    P/E N/A 
Day Low $1.14    EPS $ 
Volume 227,794